Literature DB >> 8993750

Transfer factor--current status and future prospects.

H S Lawrence1, W Borkowsky.   

Abstract

We have detected new clues to the composition and function of "Transfer Factor" using the direct Leucocyte Migration Inhibition (LMI) test as an in vitro assay of Dialysates of Leucocyte Extracts (DLE). This approach has revealed two opposing antigen-specific activities to be present in the same > 3500 < 12,000 DA dialysis fraction - one activity is possessed of Inducer/Helper function (Inducer Factor). The opposing activity is possessed of Suppressor function (Suppressor Factor). When non-immune leucocyte populations are cultured with Inducer Factor they acquire the capacity to respond to specific antigen and inhibition of migration occurs. This conversion to reactivity is antigen-specific and dose-dependent. When immune leucocyte populations are cultured with Suppressor Factor their response to specific antigen is blocked and Inhibition of Migration is prevented.

Mesh:

Substances:

Year:  1996        PMID: 8993750     DOI: 10.1007/bf02628649

Source DB:  PubMed          Journal:  Biotherapy        ISSN: 0921-299X


  4 in total

1.  Clinical and immunological assessment in breast cancer patients receiving anticancer therapy and bovine dialyzable leukocyte extract as an adjuvant.

Authors:  Humberto H Lara; Liliana Ixtepan Turrent; Elsa N Garza-Treviño; Reyes Tamez-Guerra; Cristina Rodriguez-Padilla
Journal:  Exp Ther Med       Date:  2010-05-01       Impact factor: 2.447

2.  Induction and treatment of anergy in murine leprosy.

Authors:  Mario Juarez-Ortega; Víctor G Hernandez; Patricia Arce-Paredes; Enrique B Villanueva; Miguel Aguilar-Santelises; Oscar Rojas-Espinosa
Journal:  Int J Exp Pathol       Date:  2014-12-21       Impact factor: 1.925

3.  Preparation and properties of the specific anti-influenza virus transfer factor.

Authors:  Chongbi Li; Lihua Huang; Yanping Wang; Xiangle Li; Shaowei Liang; Yingna Zheng
Journal:  Head Face Med       Date:  2010-09-13       Impact factor: 2.151

4.  Antiviral mode of action of bovine dialyzable leukocyte extract against human immunodeficiency virus type 1 infection.

Authors:  Humberto H Lara; Liliana Ixtepan-Turrent; Elsa N Garza-Treviño; Jose I Badillo-Almaraz; Cristina Rodriguez-Padilla
Journal:  BMC Res Notes       Date:  2011-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.